Literature DB >> 23728823

HPV vaccination and sexual behavior in a community college sample.

Erica Marchand1, Beth A Glenn, Roshan Bastani.   

Abstract

Many US parents are concerned that vaccinating daughters against human papillomavirus (HPV) will communicate implicit approval for sexual activity and be associated with early or risky sexual behavior (Scarinci et al. in J Womens Health 16(8):1224-1233, 2007; Schuler et al. in Sex Transm Infect 87:349-353, 2011). The aims of this study were to understand (a) whether the HPV vaccine was associated with risky sexual behavior among a diverse sample of female adolescents and young adults, and (b) to better understand the chronology of HPV vaccination and sexual behavior. An anonymous web-based survey was used to collect data from 114 female community college students. T test and Chi square analyses were used to compare vaccinated and unvaccinated groups on age at first intercourse and proportion who had ever had sexual intercourse. Linear multiple regression was used to predict frequency of condom use and number of sexual partners in the past year, using vaccination status and demographic factors as predictors. About 38% reported receiving at least one dose of the HPV vaccine. Many of those vaccinated (45%) received the vaccine after having initiated sexual activity. The proportion of women who were sexually experienced did not differ by HPV vaccine status, nor did age at first intercourse, number of partners in the past year, or frequency of condom use. Current findings suggest that HPV vaccination is not associated with riskier sexual activity for the young women in this sample. Adolescents and their parents may benefit from education about the need to receive the HPV vaccine before onset of sexual activity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23728823      PMCID: PMC3823717          DOI: 10.1007/s10900-013-9710-0

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  19 in total

1.  Mother-daughter communication and human papillomavirus vaccine uptake by college students.

Authors:  Megan E Roberts; Meg Gerrard; Rachel Reimer; Frederick X Gibbons
Journal:  Pediatrics       Date:  2010-04-12       Impact factor: 7.124

Review 2.  Factors affecting transmission of mucosal human papillomavirus.

Authors:  Nienke J Veldhuijzen; Peter Jf Snijders; Peter Reiss; Chris Jlm Meijer; Janneke Hhm van de Wijgert
Journal:  Lancet Infect Dis       Date:  2010-11-11       Impact factor: 25.071

3.  Recommended adult immunization schedule--United States, 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-02-04       Impact factor: 17.586

4.  The Primary Care Assessment Survey: tests of data quality and measurement performance.

Authors:  D G Safran; M Kosinski; A R Tarlov; W H Rogers; D H Taira; N Lieberman; J E Ware
Journal:  Med Care       Date:  1998-05       Impact factor: 2.983

5.  Human papillomavirus vaccine and behavioural disinhibition.

Authors:  Christine L Schuler; Paul L Reiter; Jennifer S Smith; Noel T Brewer
Journal:  Sex Transm Infect       Date:  2011-02-25       Impact factor: 3.519

6.  Parental decision making about the HPV vaccine.

Authors:  Jennifer D Allen; Megan K D Othus; Rachel C Shelton; Yi Li; Nancy Norman; Laura Tom; Marcela G del Carmen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-09       Impact factor: 4.254

7.  Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years.

Authors:  B Romanowski; P Colares de Borba; P S Naud; C M Roteli-Martins; N S De Carvalho; J C Teixeira; F Aoki; B Ramjattan; R M Shier; R Somani; S Barbier; M M Blatter; C Chambers; D Ferris; S A Gall; F A Guerra; D M Harper; J A Hedrick; D C Henry; A P Korn; R Kroll; A-B Moscicki; W D Rosenfeld; B J Sullivan; C S Thoming; S K Tyring; C M Wheeler; G Dubin; A Schuind; T Zahaf; Mary Greenacre; An Sgriobhadair
Journal:  Lancet       Date:  2009-12-12       Impact factor: 79.321

8.  Prevalence of sexually transmitted infections among female adolescents aged 14 to 19 in the United States.

Authors:  Sara E Forhan; Sami L Gottlieb; Maya R Sternberg; Fujie Xu; S Deblina Datta; Geraldine M McQuillan; Stuart M Berman; Lauri E Markowitz
Journal:  Pediatrics       Date:  2009-11-23       Impact factor: 7.124

9.  An examination of acceptability of HPV vaccination among African American women and Latina immigrants.

Authors:  Isabel C Scarinci; Isabel C Garcés-Palacio; Edward E Partridge
Journal:  J Womens Health (Larchmt)       Date:  2007-10       Impact factor: 2.681

10.  Noninfluenza vaccination coverage among adults - United States, 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-02-01       Impact factor: 17.586

View more
  14 in total

1.  Biopower, Normalization, and HPV: A Foucauldian Analysis of the HPV Vaccine Controversy.

Authors:  Kimberly S Engels
Journal:  J Med Humanit       Date:  2016-09

2.  HPV Misconceptions Among College Students: The Role of Health Literacy.

Authors:  Amy E Albright; Rebecca S Allen
Journal:  J Community Health       Date:  2018-12

3.  Racial/Ethnic Disparities in HPV Vaccine Uptake Among a Sample of College Women.

Authors:  Chukwuemeka Okafor; Xingdi Hu; Robert L Cook
Journal:  J Racial Ethn Health Disparities       Date:  2014-12-04

4.  Risk perceptions after human papillomavirus vaccination are not subsequently associated with riskier behaviors or sexually transmitted infections in HIV-infected young women.

Authors:  Rachel Thomas; Mary Dillard; Jiahong Xu; Gregory D Zimet; Jessica A Kahn
Journal:  Hum Vaccin Immunother       Date:  2019-06-03       Impact factor: 3.452

5.  Sexual behavior, clinical outcomes and attendance of cervical cancer screening by HPV vaccinated and unvaccinated sexually active women.

Authors:  Chantal Sauvageau; Vladimir Gilca; Manale Ouakki; Marilou Kiely; François Coutlée; Sara Mathieu-Chartier; Fannie Defay; Gilles Lambert
Journal:  Hum Vaccin Immunother       Date:  2021-08-19       Impact factor: 4.526

6.  Nativity Disparities in Human Papillomavirus Vaccination Among U.S. Adults.

Authors:  Ashley E Pérez; Madina Agénor; Kristi E Gamarel; Don Operario
Journal:  Am J Prev Med       Date:  2017-12-11       Impact factor: 5.043

7.  Brazilian Protocol for Sexually Transmitted Infections 2020: human papillomavirus (HPV) infection.

Authors:  Newton Sergio de Carvalho; Roberto José de Carvalho da Silva; Isabel Cristina do Val; Maria Luiza Bazzo; Mariângela Freitas da Silveira
Journal:  Rev Soc Bras Med Trop       Date:  2021-05-17       Impact factor: 1.581

Review 8.  Tempest in a teapot: A systematic review of HPV vaccination and risk compensation research.

Authors:  Monica L Kasting; Gilla K Shapiro; Zeev Rosberger; Jessica A Kahn; Gregory D Zimet
Journal:  Hum Vaccin Immunother       Date:  2016-02-10       Impact factor: 3.452

9.  Changes in (risk) behavior and HPV knowledge among Dutch girls eligible for HPV vaccination: an observational cohort study.

Authors:  Robine Donken; Adriana Tami; Mirjam J Knol; Karin Lubbers; Marianne A B van der Sande; Hans W Nijman; Toos Daemen; Willibrord C M Weijmar Schultz; Hester E de Melker
Journal:  BMC Public Health       Date:  2018-07-05       Impact factor: 3.295

10.  Cervical cancer risk perceptions, sexual risk behaviors and sexually transmitted infections among Bivalent Human Papillomavirus vaccinated and non-vaccinated young women in Uganda - 5 year follow up study.

Authors:  Edward Kumakech; Sören Andersson; Henry Wabinga; Caroline Musubika; Samuel Kirimunda; Vanja Berggren
Journal:  BMC Womens Health       Date:  2017-06-02       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.